Stock listing
KRX:206640 Boditech Med, Inc. (바디텍메드) 주가
Follow Boditech Med, Inc. into a list and get an email when it puts out news.
Share price · KRX:206640
₩9,580.00 KRW -230.00 (-2.3%)
Close on Nov 20, 2026
- Day range
- ₩9,360.00 – ₩9,870.00 KRWNov 20, 2026
- Volume
- 23,855 sharesNov 20, 2026
- Market cap
- ₩204.6B KRWAt the close on Nov 20, 2026 · price × 21.35M shares outstanding
- 52-week range
- ₩7,980.00 – ₩14,150.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩287.9M KRWMedian day 25,703 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:206640 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩9,580.00 | -230.00 | -2.3% | ₩9,870.00 | ₩9,870.00 | ₩9,360.00 | 23,855 | |
| ₩9,810.00 | +110.00 | +1.1% | ₩9,700.00 | ₩9,810.00 | ₩9,520.00 | 12,128 | |
| ₩9,700.00 | -50.00 | -0.5% | ₩9,870.00 | ₩9,960.00 | ₩9,500.00 | 27,537 | |
| ₩9,750.00 | -140.00 | -1.4% | ₩9,940.00 | ₩10,090.00 | ₩9,710.00 | 54,920 | |
| ₩9,890.00 | +320.00 | +3.3% | ₩9,780.00 | ₩10,080.00 | ₩9,780.00 | 61,502 | |
| ₩9,570.00 | +270.00 | +2.9% | ₩9,250.00 | ₩9,690.00 | ₩9,250.00 | 27,244 | |
| ₩9,300.00 | +90.00 | +1.0% | ₩9,200.00 | ₩9,340.00 | ₩9,160.00 | 27,654 | |
| ₩9,210.00 | +110.00 | +1.2% | ₩9,080.00 | ₩9,240.00 | ₩9,010.00 | 27,269 | |
| ₩9,100.00 | +300.00 | +3.4% | ₩9,010.00 | ₩9,140.00 | ₩8,940.00 | 27,479 | |
| ₩8,800.00 | -100.00 | -1.1% | ₩8,690.00 | ₩9,210.00 | ₩8,680.00 | 45,345 | |
| ₩8,900.00 | +480.00 | +5.7% | ₩8,250.00 | ₩9,020.00 | ₩7,980.00 | 145,578 | |
| ₩8,420.00 | +50.00 | +0.6% | ₩8,390.00 | ₩8,660.00 | ₩8,320.00 | 28,683 | |
| ₩8,370.00 | +10.00 | +0.1% | ₩8,410.00 | ₩8,450.00 | ₩8,050.00 | 41,608 | |
| ₩8,360.00 | -150.00 | -1.8% | ₩8,300.00 | ₩8,590.00 | ₩8,240.00 | 37,382 | |
| ₩8,510.00 | +110.00 | +1.3% | ₩8,390.00 | ₩8,570.00 | ₩8,050.00 | 12,277 | |
| ₩8,400.00 | -160.00 | -1.9% | ₩8,560.00 | ₩8,560.00 | ₩8,290.00 | 20,853 | |
| ₩8,560.00 | +60.00 | +0.7% | ₩8,530.00 | ₩8,620.00 | ₩8,430.00 | 27,469 | |
| ₩8,500.00 | -60.00 | -0.7% | ₩8,600.00 | ₩8,710.00 | ₩8,390.00 | 43,362 | |
| ₩8,560.00 | +110.00 | +1.3% | ₩8,520.00 | ₩8,780.00 | ₩8,490.00 | 30,581 | |
| ₩8,450.00 | -130.00 | -1.5% | ₩8,450.00 | ₩8,590.00 | ₩8,360.00 | 7,928 | |
| ₩8,580.00 | +80.00 | +0.9% | ₩8,380.00 | ₩8,580.00 | ₩8,350.00 | 17,390 | |
| ₩8,500.00 | -420.00 | -4.7% | ₩8,850.00 | ₩8,880.00 | ₩8,400.00 | 64,058 | |
| ₩8,920.00 | -60.00 | -0.7% | ₩9,070.00 | ₩9,150.00 | ₩8,880.00 | 14,144 | |
| ₩8,980.00 | -170.00 | -1.9% | ₩9,180.00 | ₩9,330.00 | ₩8,960.00 | 19,940 | |
| ₩9,150.00 | +30.00 | +0.3% | ₩8,920.00 | ₩9,150.00 | ₩8,870.00 | 20,636 | |
| ₩9,120.00 | -30.00 | -0.3% | ₩9,220.00 | ₩9,290.00 | ₩9,050.00 | 64,076 | |
| ₩9,150.00 | -240.00 | -2.6% | ₩9,220.00 | ₩9,240.00 | ₩8,900.00 | 44,501 | |
| ₩9,390.00 | -20.00 | -0.2% | ₩9,420.00 | ₩9,590.00 | ₩9,270.00 | 19,120 | |
| ₩9,410.00 | -190.00 | -2.0% | ₩9,500.00 | ₩9,500.00 | ₩9,280.00 | 18,388 | |
| ₩9,600.00 | -190.00 | -1.9% | ₩9,880.00 | ₩9,880.00 | ₩9,510.00 | 32,261 | |
| ₩9,790.00 | -140.00 | -1.4% | ₩9,860.00 | ₩9,950.00 | ₩9,770.00 | 19,104 | |
| ₩9,930.00 | +210.00 | +2.2% | ₩9,810.00 | ₩10,190.00 | ₩9,720.00 | 59,051 | |
| ₩9,720.00 | -30.00 | -0.3% | ₩9,770.00 | ₩9,850.00 | ₩9,660.00 | 14,558 | |
| ₩9,750.00 | +50.00 | +0.5% | ₩9,620.00 | ₩9,770.00 | ₩9,620.00 | 16,327 | |
| ₩9,700.00 | +110.00 | +1.1% | ₩9,600.00 | ₩9,730.00 | ₩9,450.00 | 14,913 | |
| ₩9,590.00 | +160.00 | +1.7% | ₩9,510.00 | ₩9,660.00 | ₩9,470.00 | 13,584 | |
| ₩9,430.00 | -110.00 | -1.2% | ₩9,530.00 | ₩9,530.00 | ₩9,360.00 | 11,849 | |
| ₩9,540.00 | +190.00 | +2.0% | ₩9,420.00 | ₩9,640.00 | ₩9,300.00 | 22,491 | |
| ₩9,350.00 | +50.00 | +0.5% | ₩9,390.00 | ₩9,420.00 | ₩9,260.00 | 28,490 | |
| ₩9,300.00 | -150.00 | -1.6% | ₩9,440.00 | ₩9,440.00 | ₩9,250.00 | 36,289 | |
| ₩9,450.00 | +110.00 | +1.2% | ₩9,400.00 | ₩9,540.00 | ₩9,360.00 | 17,969 | |
| ₩9,340.00 | -70.00 | -0.7% | ₩9,410.00 | ₩9,480.00 | ₩9,280.00 | 21,415 | |
| ₩9,410.00 | -60.00 | -0.6% | ₩9,470.00 | ₩9,490.00 | ₩9,330.00 | 11,418 | |
| ₩9,470.00 | +40.00 | +0.4% | ₩9,400.00 | ₩9,530.00 | ₩9,260.00 | 26,313 | |
| ₩9,430.00 | -180.00 | -1.9% | ₩9,480.00 | ₩9,620.00 | ₩9,400.00 | 25,244 | |
| ₩9,610.00 | +10.00 | +0.1% | ₩9,580.00 | ₩9,620.00 | ₩9,430.00 | 19,722 | |
| ₩9,600.00 | +80.00 | +0.8% | ₩9,510.00 | ₩9,640.00 | ₩9,400.00 | 16,614 | |
| ₩9,520.00 | -130.00 | -1.3% | ₩9,650.00 | ₩9,650.00 | ₩9,310.00 | 52,112 | |
| ₩9,650.00 | -80.00 | -0.8% | ₩9,770.00 | ₩9,780.00 | ₩9,530.00 | 75,792 | |
| ₩9,730.00 | -20.00 | -0.2% | ₩9,830.00 | ₩9,900.00 | ₩9,710.00 | 14,517 | |
| ₩9,750.00 | -10.00 | -0.1% | ₩9,870.00 | ₩9,960.00 | ₩9,700.00 | 29,220 | |
| ₩9,760.00 | -50.00 | -0.5% | ₩9,890.00 | ₩9,890.00 | ₩9,630.00 | 36,317 | |
| ₩9,810.00 | -50.00 | -0.5% | ₩9,970.00 | ₩9,990.00 | ₩9,670.00 | 47,046 | |
| ₩9,860.00 | -220.00 | -2.2% | ₩10,010.00 | ₩10,050.00 | ₩9,840.00 | 29,633 | |
| ₩10,080.00 | -50.00 | -0.5% | ₩10,140.00 | ₩10,150.00 | ₩10,000.00 | 16,043 | |
| ₩10,130.00 | -240.00 | -2.3% | ₩10,370.00 | ₩10,370.00 | ₩9,780.00 | 47,990 | |
| ₩10,370.00 | +270.00 | +2.7% | ₩10,230.00 | ₩10,370.00 | ₩10,070.00 | 19,654 | |
| ₩10,100.00 | -240.00 | -2.3% | ₩10,400.00 | ₩10,400.00 | ₩10,100.00 | 24,390 | |
| ₩10,340.00 | +70.00 | +0.7% | ₩10,320.00 | ₩10,450.00 | ₩10,210.00 | 25,703 | |
| ₩10,270.00 | -40.00 | -0.4% | ₩10,320.00 | ₩10,320.00 | ₩9,950.00 | 40,256 | |
| ₩10,310.00 | +260.00 | +2.6% | ₩10,340.00 | ₩10,530.00 | ₩10,260.00 | 22,144 | |
| ₩10,050.00 | -400.00 | -3.8% | ₩10,370.00 | ₩10,370.00 | ₩10,000.00 | 22,689 | |
| ₩10,450.00 | +250.00 | +2.5% | ₩10,450.00 | ₩10,590.00 | ₩10,340.00 | 11,727 |
Splits
2 splits since 2016 · KRX:206640 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 11-for-10 | Split | |
| 1-for-10 | Consolidation |
- Ticker
- KRX:206640
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · Jan 6, 2026
Boditech Med To Sell 3.5 Billion Won Of Own Shares
Latest news
Boditech Med To Sell 3.5 Billion Won Of Own Shares
Jan 6, 2026
Closed ₩13,110 (-1.1%) on Jan 7, 2026
Boditech Med, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 1 in the last 12 months · 1 in all · newest Jan 6, 2026 · oldest 2026
Valuation
P/E 7.9× against a median of 41.1×: the lowest of 7 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩162.8B KRW
- P/E
- 7.9×
- EV/sales
- 0.9×
- EV/EBITDA
- 4.4×
- Price/book
- 0.8×
- Gross margin
- 58.7%
- Operating margin
- 15.3%
- Net margin
- 14.8%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Boditech Med, Inc. · KRX:206640 | US$152.0M | US$120.9M | 7.9× | 0.9× | 4.4× | 0.8× | 14.8% | 0.0× | n/a |
| Tarsons Products Limited · NSE:TARSONS | US$174.2M | US$174.2M | 146× | 3.7× | 13.5× | 2.5× | 2.5% | 0.0× | n/a |
| AVE Science & Technology Co., Ltd. Class A · SSE:688067 | US$170.2M | US$138.2M | 33.8× | 3.9× | n/a | 2.1× | 14.3% | 0.0× | n/a |
| Binex Co., Ltd · KRX:053030 | US$162.2M | US$182.2M | n/a | 1.6× | n/a | 1.4× | −18.6% | 0.4× | n/a |
| Genovis AB · OMXSTO:GENO | US$150.3M | US$142.9M | 74.9× | 10.8× | 41.7× | 5.0× | 15.1% | 0.3× | n/a |
| Genomictree, Inc. · KRX:228760 | US$147.7M | US$88.88M | n/a | 40.6× | n/a | 1.6× | −306.4% | 0.0× | n/a |
| Anbio Biotechnology · NASDAQ:NNNN | US$145.7M | US$133.8M | 22.8× | 15.5× | n/a | 4.8× | 74.1% | 0.0× | 0.56 |
| MaxCyte, Inc. · NASDAQ:MXCT | US$141.5M | US$57.06M | n/a | 1.7× | n/a | 0.9× | −81.4% | 0.1× | 0.93 |
| Shanghai Rightongene Biotechnology Co. Ltd. Class A · SSE:688217 | US$139.3M | US$102.6M | n/a | 4.6× | n/a | 1.1× | −43.9% | 0.0× | n/a |
| EKF Diagnostics Holdings plc · LSE:EKF | US$134.4M | US$115.4M | 48.4× | 1.7× | 7.1× | 1.5× | 4.1% | 0.0× | n/a |
| Bioventix PLC · LSE:BVXP | US$133.3M | US$126.3M | 13.4× | 7.4× | 9.7× | 9.2× | 57.8% | 0.0× | n/a |
| Median of the others | US$146.7M | US$130.1M | 41.1× | 4.3× | 11.6× | 1.9× | 3.3% | 0.0× | 0.75 |
Forecasts
Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 23000.00 KRW · Analysts' mean
- EPS, year to Dec 2025
- 1489.00 · 1 analyst
Team and board
| Officer | Role |
|---|---|
| Eui-Yul Choi | CEO |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Feb 13, 2023 · Before open | −1.3% |
| Q4 2021 | Mar 17, 2022 · Before open | +1.7% |
| Q3 2021 | Nov 2, 2021 · Before open | +2.4% |
| Quarter to Jun 30, 2021 | Aug 3, 2021 | +0.5% |
| Quarter to Mar 31, 2021 | May 5, 2021 · After close | +1.9% |
| Quarter to Dec 31, 2020 | Feb 16, 2021 · After close | +0.5% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 162.1B | 138.2B | 134.2B | 118.1B | 157.7B | 144.1B | 72.8B | 66.2B | 52.6B | 55.0B |
| Cost of revenue | 66.1B | 56.4B | 53.3B | 47.2B | 59.3B | 46.5B | 31.8B | 33.1B | 23.1B | 20.5B |
| Gross profit | 96.0B | 81.8B | 80.9B | 70.8B | 98.4B | 97.7B | 41.0B | 33.1B | 29.5B | 34.5B |
| Research and development | 18.6B | 16.0B | 13.4B | 14.7B | 14.3B | 11.6B | 8.88B | 9.10B | 9.93B | 7.60B |
| Selling, general and administrative | 20.2B | 35.3B | 34.8B | 28.1B | 29.8B | 18.1B | 15.6B | 16.4B | 15.9B | 13.5B |
| Operating income | 28.9B | 26.0B | 28.8B | 24.7B | 51.9B | 63.6B | 14.8B | -437.8M | -1.11B | 12.5B |
| Depreciation and amortization | 10.1B | 7.62B | 8.23B | 7.47B | 6.04B | 5.39B | 5.08B | 4.14B | 3.63B | 1.83B |
| EBITDA | 39.0B | 33.6B | 37.0B | 32.1B | 57.9B | 69.0B | 19.9B | 3.70B | 2.52B | 14.3B |
| Interest expense | 411.3M | 352.5M | 350.4M | 203.9M | 196.5M | 466.7M | 1.52B | 0 | 0 | 0 |
| Income before tax | 27.8B | 32.4B | 31.6B | 27.0B | 56.0B | 60.2B | 13.1B | -1.79B | -2.96B | 13.8B |
| Income tax | 1.68B | 8.64B | 11.9B | 1.18B | 680.8M | 181.7M | 1.53B | |||
| Net income | 23.7B | 27.3B | 25.9B | 24.2B | 44.4B | 45.5B | 11.6B | -1.69B | -2.15B | 12.6B |
| Earnings per share, basic | 1,089.60 | 1,240.44 | 1,181.07 | 1,099.41 | 1,963.92 | 1,974.14 | 508.45 | -73.07 | -93.29 | 547.95 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 19.6B | 47.9B | 42.5B | 2.50M | 2.75M | 24.0B | 20.7B | 25.7B | 22.8B | 13.0B |
| Short-term investments | 18.2B | 13.8B | 33.7B | 34.2B | 29.6B | 34.3B | 983.7M | 36.4M | 2.43B | 640.9M |
| Receivables | 37.2B | 29.3B | 26.5B | 22.1B | 24.7B | 33.9B | 15.9B | 14.5B | 12.9B | 14.3B |
| Inventory | 42.1B | 38.8B | 31.6B | 30.8B | 33.4B | 24.1B | 14.7B | 15.2B | 12.2B | 9.42B |
| Current assets | 122.6B | 135.8B | 138.7B | 117.3B | 131.1B | 121.4B | 57.7B | 62.8B | 59.3B | 41.6B |
| Property, plant and equipment | 61.9B | 56.4B | 58.2B | 45.4B | 30.8B | 31.4B | 28.8B | 27.7B | 25.4B | |
| Goodwill | 316.3M | 316.3M | 316.3M | 316.3M | 316.3M | 316.3M | 2.50B | 2.50B | 9.08B | 14.2B |
| Total assets | 281.6B | 254.7B | 227.9B | 195.7B | 192.2B | 163.5B | 101.3B | 103.4B | 108.2B | 90.8B |
| Accounts payable | 5.41B | 5.46B | 5.24B | 1.58B | 6.42B | 6.15B | 1.32B | 1.61B | 3.49B | 4.06B |
| Current liabilities | 23.4B | 27.4B | 27.3B | 16.1B | 27.1B | 33.3B | 17.2B | 14.7B | 22.1B | 11.7B |
| Long-term debt | 11.3B | 1.83B | 2.10B | 2.30B | 1.60B | 2.80B | 4.08B | 19.1B | 14.2B | 0 |
| Total debt | 8.92B | 6.41B | 24.4B | 28.4B | ||||||
| Total liabilities | 37.5B | 31.6B | 30.5B | 32.1B | 41.2B | 43.6B | 27.7B | 38.1B | 40.3B | 15.6B |
| Shareholders' equity | 231.3B | 210.3B | 186.2B | 163.6B | 151.1B | 119.9B | 73.5B | 65.3B | 67.9B | 75.2B |
| Shares outstanding | 21.7M | 22.0M | 22.0M | 22.0M | 22.6M | 23.0M | 22.9M | 23.1M | 23.0M | 23.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 22.1B | 24.9B | 34.3B | 23.1B | 49.9B | 44.6B | 17.2B | 5.31B | 886.7M | 11.8B |
| Capital spending | -34.0B | -12.5B | -5.63B | -15.3B | -18.2B | -4.08B | -4.71B | -3.59B | -5.98B | -9.83B |
| Free cash flow | -11.9B | 12.4B | 28.7B | 6.16B | 31.5B | 40.4B | 12.5B | 1.73B | -5.10B | 1.96B |
| Cash from investing | -12.0B | -16.1B | -24.5B | -15.6B | -39.9B | -852.1M | 2.00B | -14.4B | -16.6B | |
| Cash from financing | -7.98B | -1.94B | -10.2B | -19.9B | -4.11B | -18.7B | -4.07B | 23.1B | 1.41B | |
| Dividends paid | -3.27B | -4.40B | -3.30B | -4.27B | -4.61B | -1.15B | -1.16B | -1.15B | -2.09B | -2.36B |
| Share buybacks | -4.98B | -2.83B | 12.3M | -7.08B | -8.73B | 1.50B | -2.74B | 1.49B | 855.8M | 2.15B |
| Change in cash | -28.4B | 5.45B | 16.2B | -12.6B | 14.8B | 225.0M | -2.22B | 3.27B | 9.74B | -3.36B |
Cap table
Built by 6ix from Boditech Med, Inc.’s releases
- Common shares
- 21,353,021
- Fully diluted
- 21,353,021
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 21,353,021 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 21,353,021 |
Log in to ask 6ix AI your own questions about Boditech Med, Inc.